Shanghai Chest Hospital

Shanghai Chest Hospital, founded in 1957 and affiliated with Shanghai Jiao Tong University School of Medicine since 2005, is China's first tertiary hospital dedicated exclusively to cardiothoracic diseases and holds national key clinical specialties in thoracic surgery, cardiovascular medicine, and cardiac and great vessel surgery.

With over 1,000 beds and approximately 28,000 surgical procedures performed annually, the hospital was the first in mainland China to perform Da Vinci robotic-assisted thoracic surgery and has since built one of the world's highest-volume robotic thoracic programs.

The hospital pioneered multidisciplinary comprehensive treatment of lung cancer in China and was among the first centers to implement targeted therapy and immunotherapy for lung cancer, establishing the country's first dedicated lung cancer multidisciplinary team incorporating surgery, oncology, and interventional pulmonology. In 2021, the hospital's thoracic surgery service exceeded 20,000 cases in a single year, with 96.3% of pulmonary procedures performed minimally invasively, and the center consistently ranks among the top three thoracic surgery programs in national specialty rankings.